Plus Three dives deep into the world of drugs, from local decriminalization and emerging psychedelic corporations to leftist politics and mass incarceration. Each week the team and guests attempt to make sense of the complex connections between drugs, science, capitalism, policy, and culture.

Plus Three dives deep into the world of drugs, from local decriminalization and emerging psychedelic corporations to leftist politics and mass incarceration. Each week the team and guests attempt to make sense of the complex connections between drugs, science, capitalism, policy, and culture.

Plus Three dives deep into the world of drugs, from local decriminalization and emerging psychedelic corporations to leftist politics and mass incarceration. Each week the team and guests attempt to make sense of the complex connections between drugs, science, capitalism, policy, and culture.


#33 – Queering psychedelics and tripping out on gender with Jae Sevelius

Psymposia advisory board member and psychedelic researcher, Jae Sevelius, joins us to talk about queer theory, psychedelic research with transgender and gender diverse people, and what happens when political assumptions go unexamined in both research contexts and the world at large. Drawing on the work of Dr. Sevelius, as well as Dr. Devenot and Dr. Ross, we discuss some of the ways that research and social relations reproduce the logic of mainstream culture, and how queering acts as barrier to and disruption of that reproduction.

#32 – It’s All Red Flags: 5-MeO-DMT with Dr. Martin Ball

Psymposia editors discuss Dr. Martin Ball’s “session info” document that the retired 5-MeO-DMT practitioner sent to Psymposia. Dr. Ball has referenced the document in defense of his practices and cites it as evidence that his clients consented to him touching their genitals or vomiting on them while under the influence of 5-MeO-DMT.

#31 – Alex Zaitchik on Degrowth and Big Pharma

Psymposia Advisory Board member Alex Zaitchik drops in to chat about his work and experiences as an investigative journalist with a critical analysis of capitalism. Alex has covered topics ranging from the effects of extractive industry on Indigenous communities, to the existential need for degrowth, and the economics of vaccine development.

#30 – Giving a F*ck About People Who Use Drugs with Yarelix Estrada

In this episode, we're joined by our new advisory board member Yarelix Estrada to discuss her experiences with organizing psychedelic societies, psychedelic exceptionalism, and harm reduction on the streets of New York. Yarelix shares insights from her formal and practical training in public health as well as her interactions with frontline communities and her personal experiences.

#29 – The Tesla of Mental Health?

Brian Normand and David Nickles are joined by Psymposia Senior Writer Russell Hausfeld to discuss MindMed's CEO, Jamon Rahn's, recent claims that his company "may be creating effectively the Tesla of mental health,” and that the company is now a "$1B+ Unicorn.”

#28 – Qoup At The Qapitol: Q’mon Man

In this episode, we discuss a prominent participant in the bumbling coup attempt of January 6: "QAnon Shaman" Jake Angeli. Along with a coalition of Donald Trump supporters and assorted right wing ideologues, Angeli stormed the Capitol following a speech by Trump. Featuring a dissection of an "Ascension Masterclass" that was hosted on Angeli's now-deleted Star Seed Academy Facebook page, we (once again) wade into the disturbing world of psychedelic authoritarianism.

#27 – The Thought Leader and the Critic

This episode explores the rise of self-styled “thought leaders” within the psychedelic community, using Anand Giridharadas’ book “Winners Take All” as a jumping off point. Although people have been on the conference circuit for years, the recent explosion of capital investments means that there’s an unprecedented potential for money, celebrity, and status in the space.

#21 – American Trip: Ido Hartogsohn

Dr. Ido Hartoghson joins the show to talk about the ideas in his new book, American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century  Acknowledging psychedelics as non-specific amplifiers of consciousness, we discuss different historical (and present) paradigms of use in order to interrogate the role of psychedelics within our culture. As we find ourselves staring down a number of existential questions, we must ask ourselves, "What do we hope to achieve through our personal and cultural exposure to psychedelics?”


#20 – The LSD Silo Bust (Everything You Wanted to Know and a Few Things You Didn’t)

In response to the unexpected early release of William Leonard Pickard from prison, we discuss some of the characters and stories surrounding the case. Having served twenty years of a double life sentence for conspiracy to manufacture, distribute, and dispense LSD— charges which he disputes— Pickard has never spoken publicly about the specifics of his case, and some of the drug-media coverage of this story has evidenced glaring omissions. Using court documents, lesser-known first-person accounts, and excerpts from Pickard's book, The Rose of Paracelsus: On Secrets & Sacraments, we call attention to some of the murkier aspects of this story in an attempt to paint a fuller picture of what is, perhaps, the most notorious psychedelic story of the 21st century.


#19 – MDMA, PTSD, ACAB

In this episode, we explore the implications of MAPS’ main political strategy: demonstrating affinity for and utility to the police, the military, the far right, and individuals who have repeatedly upheld violent white supremacism. Unpacking a recent article by David Nickles, we examine the “ends justifies the means” logic that has become pervasive in psychedelic research.


#18 – Seizing the Doors of Perception

In this episode, we unpack some of the characters and dynamics of the psychedelic “arm” of the Intellectual Dark Web. We use Neşe Devenot’s recently released video on Jamie Wheal, Lucian Tarnowski, and other affiliates of the Rebel Wisdom media platform to explore questions of power, class, and ahistorical theories of social change. Just how much sense do these self-labelled "sensemakers" make?


#17 – Psychedelic Capitalists Part 2: Pandemic Profiteers and Non-Cooperative Actors

Brian, Dave, and Russell continue their conversation about neoliberals in psychedelia, including companies using the coronavirus pandemic to promote psychedelics for mental health. They also deconstruct non-profit vs. for-profit rhetoric and propose more pragmatic frameworks for examining the implications (and material realities) of psychedelic corporations and their operating structures, such as cooperative vs. non-cooperative.


#16 – Psychedelic Capitalists Part 1: Psilocybin and Gold and Lithium, oh my!

Brian and Dave are joined by Psymposia writer Russell Hausfeld to discuss capitalist logic in psychedelia, the principles of open science, and the increasing eagerness of extractive industry players (including gold and lithium mining outfits and traders) looking to capitalize on psychedelics.


#15 – Psychedelics, Sex, Power, Silence

In this episode, Lily Kay Ross joins us to discuss Olivia Goldhill’s story, “Psychedelic therapy has a sexual abuse problem.” Ross recently completed her doctorate studying social responses to sexual violence. She brings both her personal experience with sexual violence and poor community responses in psychedelic spaces and her academic insights to bear on the myriad of questions highlighted by Goldhill’s reporting.


#14 – Douglas Rushkoff on the Parallels Between Psychedelic and Digital Mainstreaming

Plus Three is joined by author and host of the Team Human podcast, Douglas Rushkoff, to discuss some of the parallel trajectories between psychedelic and digital mainstreaming. Will COVID-19 be to psychedelics as 9/11 was to surveillance capitalism? September 11th became the excuse to implement a surveillance state and surrender digital technologies to corporations. Will we see psychedelic medicines become the go-to recovery option for COVID-related mental health fallout? We also explore what a true psychedelic renaissance might look like.


#13 – Dear Psychedelic Researchers

On the one hand, psychedelics hold promise for personal healing and transformative individual change, and when psychedelics are eventually accepted by mainstream medicine, they will likely impact mental health outcomes for the better. But the broken systems highlighted by the coronavirus pandemic offer insight into why mental health has reached epidemic proportions in the first place.


#12 – Capitalism can’t save us from coronavirus. Neither can psychedelics.

In the midst of increasing global engagement with the fallout of the novel coronavirus, we examine some responses to the pandemic within the "psychedelic community.” Recognizing that the US has a longstanding history of privatizing profits while socializing costs, we also discuss the normalization of a "capitalist animism"—treating social phenomena like markets or financial capital as living entities—that fixates on "economic health" at the expense of public health. As this unprecedented situation continues to unfold, we explore some considerations for this sudden period of social isolation within a broader culture of social alienation.